tiprankstipranks
Blurbs

Analysts Conflicted on These Technology Names: Intel (INTC), Meta Platforms (META) and Exscientia Plc (EXAI)

Analysts have been eager to weigh in on the Technology sector with new ratings on Intel (INTCResearch Report), Meta Platforms (METAResearch Report) and Exscientia Plc (EXAIResearch Report).

Intel (INTC)

In a report released today, Stacy Rasgon from Bernstein maintained a Hold rating on Intel, with a price target of $34.00. The company’s shares closed last Tuesday at $35.69.

According to TipRanks.com, Rasgon is a 5-star analyst with an average return of 11.9% and a 56.9% success rate. Rasgon covers the Technology sector, focusing on stocks such as Infineon Technologies AG, Advanced Micro Devices, and NXP Semiconductors.

The word on The Street in general, suggests a Hold analyst consensus rating for Intel with a $36.13 average price target, implying a 2.5% upside from current levels. In a report issued on September 19, Deutsche Bank also maintained a Hold rating on the stock with a $38.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Meta Platforms (META)

Bank of America Securities analyst Justin Post reiterated a Buy rating on Meta Platforms yesterday and set a price target of $375.00. The company’s shares closed last Tuesday at $300.94, close to its 52-week high of $326.20.

According to TipRanks.com, Post is a top 100 analyst with an average return of 19.8% and a 66.0% success rate. Post covers the Technology sector, focusing on stocks such as Peloton Interactive, Uber Technologies, and Alphabet Class A.

Currently, the analyst consensus on Meta Platforms is a Strong Buy with an average price target of $376.53, implying a 23.8% upside from current levels. In a report issued on September 28, Evercore ISI also maintained a Buy rating on the stock with a $435.00 price target.

Exscientia Plc (EXAI)

Bank of America Securities analyst Alec Stranahan reiterated a Buy rating on Exscientia Plc yesterday and set a price target of $11.00. The company’s shares closed last Tuesday at $4.59, close to its 52-week low of $4.09.

According to TipRanks.com, Stranahan is a 4-star analyst with an average return of 8.2% and a 61.1% success rate. Stranahan covers the Healthcare sector, focusing on stocks such as Day One Biopharmaceuticals, Recursion Pharmaceuticals, and TG Therapeutics.

Exscientia Plc has an analyst consensus of Strong Buy, with a price target consensus of $12.50.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on INTC:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles